Drugs / GCC-4401C
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01954238 Comparator | Aug 2013 → Mar 2014 | — | Green Cross Corporation | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GCC-4401C | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01954238 ↗ |
| Action | Inhibit | “Orally active direct factor Xa inhibitor for use in the prevention and treatment of venous thromboembolic disease” NCT01954238 ↗ |
| Modality | Small molecule | — CHEMBL4300154 ↗ |
| Route | Oral | “after oral administration of GCC-4401C” NCT01954238 ↗ |